150+ IPF and pulmonary fibrosis heavyweights from leading biopharma including Genentech, AbbVie, AstraZeneca, Lassen Therapeutics, Ionis, Gilead, Pliant Therapeutics, Morphic Therapeutics and more will virtually unite this August at the 5th IPF Summit.
Our highly engaged audience of IPF experts are actively seeking to collaborate with organizations that can help them solve solutions in the development of the next generation of anti-fibrotic therapies for IPF/pulmonary fibrosis. If you’re looking to showcase your solutions, generate new business leads, and source opportunities for partnerships with senior decision makers in the IPF field, we have a strictly limited number of partnership opportunities available including virtual speaking positions across our dedicated preclinical and early translational tracks, plus late translational and clinical track.
|Secure a virtual exhibition booth to present and position your capabilities to developers who are actively seeking new solutions to optimize drug development inefficiencies|
|Network one-to-one with stakeholders during our coordinated networking sessions to first-hand understand their requirements and present your solution|
|Deliver a presentation online and still be able to influence the thinking of translational and pre-clinical scientists working to identify new promising compounds|
We’ll work with you to build a bespoke partnership package focused on making valuable connections and generating actionable leads to ensure you meet your 2021/2022 commercial objectives in this new digital reality. Contact us to learn more at firstname.lastname@example.org.
Previous Partner Testimonials
“Hanson Wade did a phenomenal job! Definitely the most productive conference so far this year regarding the number of leads and quality of networking opportunities by a lot.“
Vitalograph, IPF Summit sponsor
“You all did a great job in organizing the IPF Summit. In my book, it is a great success.”
Aragen Bioscience, IPF Summit sponsor